Physician
Pediatrics
Dr. Gregory M. Glenn, MD
|
|
Give Review
Dr. Gregory M. Glenn practices Pediatrics. He attended Oral Roberts University School of Medicine. Doctor Gregory M. Glenn, MD is a published physician. He has 103 publications published. The most current publication "Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations."
Publications
- A randomized, blinded, controlled, dose-ranging study of a respiratory syncytial virus recombinant fusion (F) nanoparticle vaccine in healthy women of childbearing age.
- Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.
- An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats ...
- Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice.
- A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine.
- Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-...
- Development of novel vaccines.
- Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats.
- Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine.
- Encapsulation of plant oils in porous starch microspheres.
- Toxin-mediated effects on the innate mucosal defenses: implications for enteric vaccines.
- Immunostimulant adjuvant patch enhances humoral and cellular immune responses to DNA immunization.
- Heat expanded starch-based compositions.
- Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum.
- GM1 binding-deficient exotoxin is a potent noninflammatory broad spectrum intradermal immunoadjuvant.
- Permeability of starch gel matrices and select films to solvent vapors.
- Dose sparing with intradermal injection of influenza vaccine.
- Induction of protective immunity against lethal anthrax challenge with a patch.
- Immunostimulant patch enhances immune responses to influenza virus vaccine in aged mice.
- Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells.
- Needle-free skin patch vaccination method for anthrax.
- Histological structures of cooked rice grain.
- Transcutaneous immunization and immunostimulant strategies.
- Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin...
- Sorption and vapor transmission properties of uncompressed and compressed microcellular starch foam.
- Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously.
- A new polymorphic probe on chromosome 3p: lambda LIB41-51 (D3S632).
- Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus.
- A new polymorphic probe on chromosome 3p: lambda LIB13-49'' (D3S723).
- A new polymorphic probe on chromosome 3p:lambda LIB25-55(D3S602).
- A new polymorphic probe on chromosome 3p: lambda LIB49-60 [D3S155].
- A new polymorphic probe on chromosome 3p: lambda LIB34-60 [D3S154].
- Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene.
- A new polymorphic probe on chromosome 3p: lambda LIB19-63'' (D3S601).
- A new polymorphic probe on chromosome 3p: lambda LIB09-75'' (D3S584).
- A new polymorphic probe on chromosome 3p: lambda LIB15-44 (D3S596).
- A new polymorphic probe on chromosome 3p: lambda LIB05-24 (D3S623).
- A new polymorphic probe on chromosome 3p: lambda LIB33-29'' (D3S629).
- A new polymorphic probe on chromosome 3p: lambda LIB08-60'''' (D3S729).
- A new polymorphic probe on chromosome 3p: lambda LIB24-12'' (D3S727).
- A new polymorphic probe on chromosome 3p: lambda LIB38-85 (D3S625).
- A new polymorphic probe on chromosome 3p: lambda LIB03-23 (D3S573).
- A new polymorphic probe on chromosome 3p: lambda LIB43-55'' (D3S728).
- A new polymorphic probe on chromosome 3p: lambda LIB31-38 (D3S726).
- A new polymorphic probe on chromosome 3p: lambda LIB37-97'''' (D3S724).
- A new polymorphic probe on chromosome 3p: lambda LIB46-100 (D3S641).
- Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.
- von Hippel-Lindau disease: genetic, clinical, and imaging features.
- Amino-terminal regions of polyomavirus middle T antigen are required for interactions with protein phosphatase 2A.
- Adenovirus 5 early region 1A host range mutants hr3, hr4, and hr5 contain point mutations which generate single amino acid substitutions.
- Transcriptional regulation of early-response genes during polyomavirus infection.
- Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activ...
- Familial renal oncocytoma: clinicopathological study of 5 families.
- Imaging features of hereditary papillary renal cancers.
- BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports.
- Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer.
- Molecular genetic studies of sporadic and familial renal cell carcinoma.
- Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization.
- Hereditary papillary renal cell carcinoma: clinical studies in 10 families.
- The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients.
- Pyridoxine as therapy in theophylline-induced seizures.
- Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents.
- Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia.
- Screening for von Hippel-Lindau disease by DNA polymorphism analysis.
- Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease.
- Vaccine adjuvants.
- Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations.
- Comorbid genetic diseases, von Hippel-Lindau disease and spinocerebellar ataxia type 2, confounding the diagnosis of cerebellar dysfunction in an adolescent.
- Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease.
- Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery.
- Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history o...
- Natural killer (NK) cell lytic dysfunction and putative NK cell receptor expression abnormality in members of a family with chromosome 3p-linked von Hippel-Lindau dise...
- Comparison of adjuvants with Leishmania antigens in a guinea pig model to induce delayed-type hypersensitivity responses.
- Induction of systemic immune responses in sheep by topical application of cholera toxin to skin.
- Effect of transcutaneous immunization with co-administered antigen and cholera toxin on systemic and mucosal antibody responses in sheep.
- Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico.
- Block-surface staining for differentiation of starch and cell walls in wheat endosperm.
- Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides.
- Induction of protective polyclonal antibodies by immunization with Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
- Advances in vaccine delivery: transcutaneous immunisation.
- Sorption of volatile flavor compounds by microcellular cereal starch.
- A simple method for studying whole sections of rice grain.
- Skin immunization made possible by cholera toxin.
- Mass vaccination: solutions in the skin.
- Murine IgG subclass antibodies to antigens incorporated in liposomes containing lipid A.
- H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in hum...
- Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
- Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine.
- Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B.
- Transcutaneous immunization: an emerging route of immunization and potent immunostimulation strategy.
- Transcutaneous immunization: a human vaccine delivery strategy using a patch.
- Transcutaneous immunization of domestic animals: opportunities and challenges.
- Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants.
- Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS,S malaria antigen.
- Principles of transcutaneous immunization using cholera toxin as an adjuvant.
- Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants.
- Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge.
- Transcutaneous immunization: T cell responses and boosting of existing immunity.
- Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants.
- Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.
- Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo.
- Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.
Schools
Oral Roberts University School of Medicine
Doctors Specialties
- Pediatrics
Accepted Insurances
Education
-
Madigan Healthcare System -
Oral Roberts University School of Medicine